GlycoMimetics Inc (GLYC)

0.242 +0.03 (+11.78%) USD  |  NASDAQ  |  Dec 24, 16:00
More

GlycoMimetics Free Cash Flow: -35.02M for Sept. 30, 2024

Free Cash Flow Chart

View Free Cash Flow for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 300.88M
Arbutus Biopharma Corp -71.92M
Revance Therapeutics Inc -194.91M
FibroGen Inc -126.23M
Cidara Therapeutics Inc -160.15M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) -7.994M
Free Cash Flow Per Share (Quarterly) -0.124
Free Cash Flow Yield -224.5%